KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Debt Ratio: 2018-2025

Historic Debt Ratio for Castle Biosciences (CSTL) over the last 4 years, with Sep 2025 value amounting to 0.02.

  • Castle Biosciences' Debt Ratio fell 8.26% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 8.26%. This contributed to the annual value of 0.02 for FY2024, which is N/A change from last year.
  • Per Castle Biosciences' latest filing, its Debt Ratio stood at 0.02 for Q3 2025, which was down 3.12% from 0.02 recorded in Q2 2025.
  • Castle Biosciences' Debt Ratio's 5-year high stood at 0.05 during Q1 2022, with a 5-year trough of 0.02 in Q3 2025.
  • In the last 2 years, Castle Biosciences' Debt Ratio had a median value of 0.02 in 2024 and averaged 0.02.
  • Data for Castle Biosciences' Debt Ratio shows a maximum YoY fell of 10.25% (in 2025) over the last 5 years.
  • Castle Biosciences' Debt Ratio (Quarterly) stood at 0.05 in 2022, then reached 0.02 in 2024, then decreased by 8.26% to 0.02 in 2025.
  • Its Debt Ratio stands at 0.02 for Q3 2025, versus 0.02 for Q2 2025 and 0.02 for Q1 2025.